Patent Reform Strategies in the Life Sciences: Assessing "First-to-File" and Freedom to Operate Under the New Rules
This webinar originally took place on May 2, 2012
Is your company ready for patent reform? With the historic passing of The America Invents Act (H.R. 1249), the intellectual property landscape for life sciences companies has changed profoundly. Many are planning for these changes now in order to protect and defend their company's most valuable assets – intellectual property.
Merrill DataSite in collaboration with CHI-California Healthcare Institute would like to invite you to an essential webinar covering these critical and complex reforms, and to provide guidance on how you can navigate through them successfully. A focused overview of the statute's "first-to-file" rules will be provided, as well as pointers for reassessing freedom to operate under the PTO's new provisions for challenging issued patents. An expert from Fish and Richardson will answer questions regarding the potential ramifications.
Steven C. Carlson
Principal, Fish & Richardson
Steve Carlson, Principal at Fish & Richardson's Silicon Valley office, litigates cases across the technology spectrum. Recent successful representations include a bench trial victory on behalf of a pioneering pharmaceutical developer of glaucoma medications, a jury trial victory over intrusion detection software, and successful enforcement of patents to polymerase chain reaction technology. Mr. Carlson is an active speaker and writer on issues of patent law drawing on his experiences as a law clerk to the Honorable Paul R. Michel of the Federal Circuit and to the Honorable Roderick R. McKelvie of the District of Delaware. He is co-author of the book Patents in Germany and Europe: Procurement, Enforcement, and Defense, written in tandem with Fish's Munich team. He is also co-author of the Patent Case Management Judicial Guide, published by the Federal Judicial Center and on the shelves of judges nationwide.